174 related articles for article (PubMed ID: 36405012)
21. Identification of MAN1B1 as a Novel Marker for Bladder Cancer and Its Relationship with Immune Cell Infiltration.
Wang X; Chen B; Cao Y; He Y; Chen W
J Oncol; 2022; 2022():3387671. PubMed ID: 36016584
[TBL] [Abstract][Full Text] [Related]
22. Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
Qiu L; Levine K; Gajiwala KS; Cronin CN; Nagata A; Johnson E; Kraus M; Tatlock J; Kania R; Foley T; Sun S
PLoS One; 2018; 13(6):e0198374. PubMed ID: 29879184
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
24. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
[TBL] [Abstract][Full Text] [Related]
25. A Novel HCC Prognosis Predictor EEF1E1 Is Related to Immune Infiltration and May Be Involved in EEF1E1/ATM/p53 Signaling.
Han R; Feng P; Pang J; Zou D; Li X; Geng C; Li L; Min J; Shi J
Front Oncol; 2021; 11():700972. PubMed ID: 34282404
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of protein tyrosine kinase 6 overexpression in cancers: a meta-analysis.
Jeong SY; Kim JH; Lee JJ; Park ST; Kim HS
Front Biosci (Landmark Ed); 2022 Feb; 27(2):60. PubMed ID: 35227003
[TBL] [Abstract][Full Text] [Related]
27. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
[TBL] [Abstract][Full Text] [Related]
28. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract][Full Text] [Related]
29. In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues.
Aubele M; Spears M; Ludyga N; Braselmann H; Feuchtinger A; Taylor KJ; Lindner K; Auer G; Stering K; Höfler H; Schmitt M; Bartlett JM
Br J Cancer; 2010 Aug; 103(5):663-7. PubMed ID: 20700126
[TBL] [Abstract][Full Text] [Related]
30. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
[TBL] [Abstract][Full Text] [Related]
31. PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors.
Peng M; Emmadi R; Wang Z; Wiley EL; Gann PH; Khan SA; Banerji N; McDonald W; Asztalos S; Pham TN; Tonetti DA; Tyner AL
Oncotarget; 2014 Aug; 5(15):6038-48. PubMed ID: 25153721
[TBL] [Abstract][Full Text] [Related]
32. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
33. Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.
Zheng Y; Tyner AL
Eur J Clin Invest; 2013 Apr; 43(4):397-404. PubMed ID: 23398121
[TBL] [Abstract][Full Text] [Related]
34. The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.
Brauer PM; Zheng Y; Evans MD; Dominguez-Brauer C; Peehl DM; Tyner AL
PLoS One; 2011 Mar; 6(3):e14789. PubMed ID: 21479203
[TBL] [Abstract][Full Text] [Related]
35. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
36. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
Zhang B; Wang Q; Fu C; Jiang C; Ma S
Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746
[TBL] [Abstract][Full Text] [Related]
37. Reduced Expression of KRT17 Predicts Poor Prognosis in HER2
Tang S; Liu W; Yong L; Liu D; Lin X; Huang Y; Wang H; Cai F
Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139022
[TBL] [Abstract][Full Text] [Related]
38. Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.
Mathur PS; Gierut JJ; Guzman G; Xie H; Xicola RM; Llor X; Chastkofsky MI; Perekatt AO; Tyner AL
Mol Cancer Res; 2016 Jun; 14(6):563-73. PubMed ID: 26983689
[TBL] [Abstract][Full Text] [Related]
39. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
40. Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells.
Ludyga N; Anastasov N; Rosemann M; Seiler J; Lohmann N; Braselmann H; Mengele K; Schmitt M; Höfler H; Aubele M
Mol Cancer Res; 2013 Apr; 11(4):381-92. PubMed ID: 23364537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
